Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
Biotech
ESMO: Pfizer sees year-long weight gain in cancer patients
For the second year running, Pfizer has arrived at ESMO armed with data showing that ponsegromab can treat a wasting syndrome.
James Waldron
Oct 17, 2025 12:45pm
Boehringer digs in on ADCs with $991M AimedBio licensing accord
Oct 15, 2025 10:05am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
Exact Sciences rolls out Cancerguard multi-cancer blood test
Sep 11, 2025 1:00pm
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
